Healthy Skepticism Library item: 6268
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Shulman LP, Bateman LH, Creinin MD, Cullins VE, Doyle LL, Godfrey E, Murphy P, Rodriguez P, Spear SJ, Stewart FH, Thomas MA, Westhoff CL, Worthington S.
Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation: evidence-based clinical science should guide FDA decision making about product labeling.
Contraception 2006 May 01; 73:(5):440-2
http://linkinghub.elsevier.com/retrieve/pii/S0010-7824(06)00034-5
Keywords:
Biological Markers
Communication
Contraceptive Agents, Female*
Drug Labeling/standards*
Evidence-Based Medicine
Female
Humans
United States
United States Food and Drug Administration
